GcMaf - A breakthrough in Cancer treatment

GcMaf is the abbreviation for "Gc-protein-derived macrophage activating factor". It is found naturally in the body but there is now a way of administering it as a replacement therapy when the body's defences aren't doing enough. Macrophages are the white cells that go in like 'Pac man' and engulf and digest foreign substances, microbes and cancer cells in a process called phagocytosis.

Interestingly it is completely in line with all the nutritional guidelines that have been developing for the treatment of Autoimmune Diseases that I have been writing about in Millenniumhealth blog.

The treatment regime is called "The Swiss Protocol" and involves-

• Total body ultrasound to establish the extent of the disease followed by an individual treatment plan.
• High protein, low carbohydrate, ant-inflammatory and detoxing diet - so essentially a Paleo-ketogenic diet 
• Amino acid supplements in the case of cancer and Autism
• Bravo Probiotic Yogurt and suppositories that have over 40 strains of friendly probiotic bacteria  and these produce the enzymes needed to activate GcMaf.
• GOleic -which is a combination of GcMaf, Oleic Acid a monosaturated (Omega-9) fatty acid and vitamin D. This can be administered in a variety of ways:- injection, drops under the tongue, enemas, suppositories, nebuliser (spray), ointment and mouthwash.

The Company producing GOleic is called Immuno Biotec (Guernsey) and they also sell Bravo Probiotic yogurt.

For more information go to www.gcmaf.eu

More than 60 peer reviewed research papers have been produced by 154 scientists who have trialled

it on a range of different diseases. There are approximately 300 doctors following the protocol and there are some amazing stories of recovery (even from stage 4 cancers) as well as some considerable improvement in patients with Autism. Some people do not respond to the protocol but then they may have already received treatment like chemotherapy and radiation and their detoxifying capability and nutritional status may be compromised. It is relatively early days but all this sounds extremely promising and clinical trials are ongoing.